Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
The WICD-MI Study
Author(s): Mathieu Echivard Added: 11 months ago
ESC HFA 25 - The WICD-MI study finds heart failure to be frequent in patients with persistent left ventricular dysfunction after acute myocardial infarction.We are joined onsite by Dr Mathieu Echivard (University Hospital of Nancy, Nancy, FR) to discuss key findings from a study investigating heart failure events in patients with persistent left ventricular dysfunction after acute myocardial… View more

MI/ACS

Heart Failure
A Preferred Substrate-based Nomenclature in Myocardial Ischaemic Syndromes
Author(s): William E Boden , Juan Carlos Kaski , C Noel Bairey Merz , et al Added: 11 months ago

MI/ACS
Atorvastatin and Ezetimibe in Patients with Acute Coronary Syndrome
Author(s): Mohammed Sallam , Hossameldin Hassan , Derek Connolly , et al Added: 1 year ago

Prevention & Chronic Conditions

MI/ACS
Could Acute COVID-19 Infection Ignite Thrombotic Risk?
Author(s): Joshua Stolker , Philippe Gabriel Steg , Roberta Rossini , et al Added: 11 months ago

COVID-19

MI/ACS
Symptomology, Outcomes and Risk Factors of Acute Coronary Syndrome Presentations without Cardiac Chest Pain: A Scoping Review
Author(s): Meriem Perona , Amanda Cooklin , Christopher Thorpe , et al Added: 1 year ago

MI/ACS
Ep 121: OMI/NOMI: A Paradigm Shift in Myocardial Infarction Diagnosis
Added: 1 year ago
In this week's episode of Parallax, host Dr Ankur Kalra engages in a thought-provoking discussion with Dr Stephen Smith, a pioneer in electrocardiography and myocardial infarction diagnosis. They delve into the groundbreaking OMI/NOMI paradigm (Occlusion MI vs Non-Occlusion MI), challenging the traditional STEMI vs non-STEMI terminology that has long been the cornerstone of acute coronary… View more

Prevention & Chronic Conditions

MI/ACS
ESC 25: The REBOOT-CNIC Trial
Author(s): Borja Ibanez Added: 7 months ago
ESC Congress 2025 - REBOOT-MI finds that beta-blocker therapy after MI did not reduce the occurrence of adverse events in patients with LVEF greater than 40%.Dr Borja Ibanez (National Centre for Cardiovascular Research, Madrid, ES) joins us to discuss findings from REBOOT-CNIC (NCT03596385). The prospective, randomised, open-label trial investigated the benefits of long-term betablocker therapy… View more

MI/ACS

Heart Failure
Amy Li

Author

Research Area(s) / Expertise:

Cardiomyopathies

 Job title: Associate Professor of Cardiovascular Sciences
A/Prof Li is the Co-lead of the Chronic Disease Theme in the Centre of Healthy Futures and Higher Degree Research Director of Health. Her direct research interests cover cardiovascular and musculoskeletal physiology utilising a combination of biophysical, imaging and omics techniques. She combines her extensive pre- and post-doctoral training from internationally leading biophysics and physiology… View more